Recently, Galectin 3 has been implicated in the development of a number of diseases such as cancer, stroke, and inflammatory-driven pathological conditions (Dumic et al., 2006;, Henderson and Sethi, 2009; Rahimian et al., 2021). The gene discussed is LGALS3; the disease is Stroke.